What type of study is this?

This is a In Vitro Study study.

October 9, 20251 citationsOpen Access

Partial STX11 deficiency due to a hypomorphic variant—self-limiting inflammatory disease preceding HLH onset

TNTahereh NooriPeter MacCallum Cancer Centre AKA KaurPost Graduate Institute of Medical Education and Research AKAltaf Hussain KambayGovernment Medical College

Key Points

Self-limiting inflammatory disease identified in a patient with a hypomorphic STX11 variant, leading to HLH.
In vitro analysis confirmed atypical familial hemophagocytic lymphohistiocytosis (FHL) diagnosis for the patient.
Clinicians proceeded confidently with hematopoietic stem cell transplantation based on definitive mutation findings.
The study highlights the relevance of characterizing uncharacterized mutations in clinical decision-making.

Abstract

Recently developed in vitro technology was used to define the function of a previously uncharacterized STX11 mutation L135P present in a patient with atypical FHL. The results confirmed the FHL diagnosis and enabled clinicians to proceed with assurance to hematopoietic stem cell transplantation.

AI에게 질문

Bookmark

View Full Paper